Bayesian Capital Management, LP Ginkgo Bioworks Holdings, Inc. Transaction History

Bayesian Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.28 - $1.16 $1,092 - $4,524	3,900 Added 21.31%	22,200 $7,000
Q1 2024 May 15, 2024	BUY	$1.06 - $1.67 $19,398 - $30,561	18,300 New	18,300 $21,000
Q3 2023 Nov 14, 2023	BUY	$1.61 - $2.54 $38,318 - $60,452	23,800 New	23,800 $43,000
Q2 2022 Aug 15, 2022	SELL	$2.2 - $4.2 $96,140 - $183,540	-43,700 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.83 - $8.69 $43,865 - $134,695	15,500 Added 54.96%	43,700 $176,000
Q4 2021 Feb 14, 2022	BUY	$8.31 - $14.92 $234,342 - $420,744	28,200 New	28,200 $234,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $13.2B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.